25 May 2013
Keywords: bioalliance, extends, loramyc, license, china, paris, france-based
Article | 30 June 2008
Paris, France-based BioAlliance Pharma SA, which is focused on the treatment of opportunistic infections in cancer and HIV, has entered
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
24 May 2013
© 2013 thepharmaletter.com